J. Joseph Melenhorst

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Decade-long leukaemia remissions with persistence of CD4+ CAR T cells”.

Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

Nature(2022)10.1038/s41586-021-04390-6

N/A

10.2DataRank · unranked

929 citations

Gregory M. Chen, Meng Wang, David L. Porter, Changya Chen, McKensie Collins +29 more

Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0018

N/A

0.709DataRank · unranked

112 citations

Adam D. Cohen, Akhilesh Kaushal, Alfred L. Garfall, Renee Julia Manalo, Allison R. Carr +8 more

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma

Frontiers in Oncology(2021)10.3389/fonc.2021.669071

N/A

0.648DataRank · unranked

74 citations

Fraser Henderson, MacLean P. Nasrallah, Suyash Mohan, Sumei Wang, Simon F. Lacey +10 more

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0822

N/A

0.633DataRank · unranked

67 citations

Rawan Shraim, Regina M. Myers, Edward M. Behrens, Scott Canna, Hamid Bassiri +21 more

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer

Molecular Therapy(2020)10.1016/j.ymthe.2020.07.017

N/A

0.606DataRank · unranked

56 citations

Alexander C. Jordan, Evan Tooker, Simon F. Lacey, Renee B. Chang, Yan Li +11 more

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0308

N/A

0.561DataRank · unranked

41 citations

Adam D. Cohen, Simon F. Lacey, Megan M. Davis, Alfred L. Garfall, J. Joseph Melenhorst +11 more

B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?

Science Translational Medicine(2022)10.1126/scitranslmed.abn3353

N/A

0.464DataRank · unranked

21 citations

J. Joseph Melenhorst, Kai Tan, Gregory M. Chen

B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy

British Journal of Haematology(2021)10.1111/bjh.17397

N/A

0.373DataRank · unranked

11 citations

Lifeng Tian, Alfred L. Garfall, J. Joseph Melenhorst, Simon F. Lacey, Edward A. Stadtmauer +10 more

Cancer stem cells: advances in biology and clinical translation—a Keystone Symposia report

Annals of the New York Academy of Sciences(2021)10.1111/nyas.14719

N/A

0.360DataRank · unranked

10 citations

Duanqing Pei, Lola M. Reid, Sophie Wang, Sonam Bhatia, Panagiotis Karras +25 more

Decade-long remissions of leukemia sustained by the persistence of activated CD4 + CAR T-cells

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.07.443194

N/A

0.165DataRank · unranked

2 citations

Gregory M. Chen, Meng Wang, David L. Porter, Peng Gao, Shovik Bandyopadhyay +23 more

Decade-long remissions of leukemia sustained by the persistence of activated CD4+ CAR T-cells

Research Square(2021)10.21203/rs.3.rs-505891/v1

N/A

0.104DataRank · unranked

1 citations

Gregory Chen, Meng Wang, David L. Porter, Peng Gao, Shovik Bandyopadhyay +23 more

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0200

N/A

0DataRank · unranked

13 citations

In-Young Jung, Ziran Zhao, Kimberly Apodaca, Weimin Kong, Stefan Lundh +6 more

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.027

N/A

0DataRank · unranked

3 citations

Nizar J. Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolò Bolli, Carrie Brownstein +18 more

Challenges and opportunities of CAR T-cell therapies for CLL

Seminars in Hematology(2023)10.1053/j.seminhematol.2023.01.002

N/A

0DataRank · unranked

5 citations

Céline Grégoire, Beatriz Coutinho de Oliveira, Kunho Chung, J. Joseph Melenhorst, Ziran Zhao

Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies

Blood Reviews(2024)10.1016/j.blre.2024.101241

N/A

0DataRank · unranked

21 citations

Céline Grégoire, Beatriz Coutinho de Oliveira, J. Joseph Melenhorst, Arun Kumar Arunachalam

Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell Effectiveness

Cancers(2025)10.3390/cancers17030383

N/A

0DataRank · unranked

3 citations

S. M. Nayeemul Bari, J. Joseph Melenhorst, Beatriz Coutinho de Oliveira

MCL1 may not mediate chemoresistance

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.22.671824

N/A

0DataRank · unranked

0 citations

Kunho Chung, Dongmei Zhang, Belinda Willard, Timothy A. Chan, Babal K. Jha +4 more